Uploaded March 2026 | Updated September 2026, 3 weeks ago
“Chemical synthesis testing is one of the pharmaceutical industry’s biggest challenges,” says Louis Dron, one of the founders of Vancouver-based Redwood AI. The company has turned its attention to solving that bottleneck and, at the same time, propelling Vancouver to the centre of chemical synthesis testing aimed at global pharma.
Redwood AI’s proprietary software and analytic solutions synthesis test is trained on more than one billion molecules and reactions. “Our system evaluates manufacturing pathways in seconds,” says Dron. The platform the company created predicts and optimizes synthesis pathways across drug discovery and development, which enables chemists to design, refine, and scale compounds with greater precision and efficiency.
“Key to the success of our platform is its ability to integrate across the drug development lifecycle by embedding predictive intelligence into chemical decision making processes,” says Dron. “It’s a game-changer for the pharmaceutical industry and for Vancouver.”
We invited Louis Dron the CEO of Redwood AI to join us for a Conversation That Matters about the convergence of advanced chemistry and AI.
---
Your support matters! Become a patron and subscribe: goo.gl/ypXyDs
The views discussed in this video are the opinions of our guests and do not necessarily reflect the opinions of Oh Boy Productions or this show. Any images in this video are for fair use only, as we are a journalism outlet that seeks to illustrate the topic or guest involved.
ctm599 #ai #chemicals #artificialintelligence
“Chemical synthesis testing is one of the pharmaceutical industry’s biggest challenges,” says Louis Dron, one of the founders of Vancouver-based Redwood AI. The company has turned its attention to solving that bottleneck and, at the same time, propelling Vancouver to the centre of chemical synthesis testing aimed at global pharma.
Redwood AI’s proprietary software and analytic solutions synthesis test is trained on more than one billion molecules and reactions. “Our system evaluates manufacturing pathways in seconds,” says Dron. The platform the company created predicts and optimizes synthesis pathways across drug discovery and development, which enables chemists to design, refine, and scale compounds with greater precision and efficiency.
“Key to the success of our platform is its ability to integrate across the drug development lifecycle by embedding predictive intelligence into chemical decision making processes,” says Dron. “It’s a game-changer for the pharmaceutical industry and for Vancouver.”
We invited Louis Dron the CEO of Redwood AI to join us for a Conversation That Matters about the convergence of advanced chemistry and AI.
---
Your support matters! Become a patron and subscribe: goo.gl/ypXyDs
The views discussed in this video are the opinions of our guests and do not necessarily reflect the opinions of Oh Boy Productions or this show. Any images in this video are for fair use only, as we are a journalism outlet that seeks to illustrate the topic or guest involved.
ctm599 #ai #chemicals #artificialintelligence
